Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance.

Edwardson DW, Boudreau J, Mapletoft J, Lanner C, Kovala AT, Parissenti AM.

PLoS One. 2017 Sep 15;12(9):e0183662. doi: 10.1371/journal.pone.0183662. eCollection 2017.

2.

RNA disruption is associated with response to multiple classes of chemotherapy drugs in tumor cell lines.

Narendrula R, Mispel-Beyer K, Guo B, Parissenti AM, Pritzker LB, Pritzker K, Masilamani T, Wang X, Lannér C.

BMC Cancer. 2016 Feb 24;16:146. doi: 10.1186/s12885-016-2197-1.

3.

Error-promoting DNA synthesis in ovarian cancer cells.

Dai H, Hickey RJ, Liu J, Bigsby RM, Lanner C, Malkas LH.

Gynecol Oncol. 2013 Oct;131(1):198-206. doi: 10.1016/j.ygyno.2013.06.022. Epub 2013 Jul 12.

4.

Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel.

Armstrong SR, Narendrula R, Guo B, Parissenti AM, McCallum KL, Cull S, Lannér C.

J Ovarian Res. 2012 Nov 30;5(1):40. doi: 10.1186/1757-2215-5-40.

5.

Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.

Sprowl JA, Reed K, Armstrong SR, Lanner C, Guo B, Kalatskaya I, Stein L, Hembruff SL, Tam A, Parissenti AM.

Breast Cancer Res. 2012 Jan 6;14(1):R2.

6.

The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer.

Richard C, Lanner C, Naryzhny SN, Sherman L, Lee H, Lambert PF, Zehbe I.

Oncogene. 2010 Jun 10;29(23):3435-45. doi: 10.1038/onc.2010.93. Epub 2010 Apr 12.

PMID:
20383192
7.

Type 1 phosphatase, a negative regulator of cardiac function.

Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Jing SL, Allen PB, Greengard P, Yatani A, Hoit BD, Grupp IL, Hajjar RJ, DePaoli-Roach AA, Kranias EG.

Mol Cell Biol. 2002 Jun;22(12):4124-35.

8.

Gene structure and expression of the targeting subunit, RGL, of the muscle-specific glycogen-associated type 1 protein phosphatase, PP1G.

Lannér C, Suzuki Y, Bi C, Zhang H, Cooper LD, Bowker-Kinley MM, DePaoli-Roach AA.

Arch Biochem Biophys. 2001 Apr 1;388(1):135-45.

PMID:
11361130
9.

Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL.

Suzuki Y, Lanner C, Kim JH, Vilardo PG, Zhang H, Yang J, Cooper LD, Steele M, Kennedy A, Bock CB, Scrimgeour A, Lawrence JC Jr, DePaoli-Roach AA.

Mol Cell Biol. 2001 Apr;21(8):2683-94.

10.

Relationships of wild Brassica species with chromosome number 2n = 18, based on RFLP studies.

Lannér C, Bryngelsson T, Gustafsson M.

Genome. 1997 Jun;40(3):302-8.

PMID:
18464831
11.

Genetic validity of RAPD markers at the intra- and inter-specific level in wild Brassica species with n=9.

Lannér C, Bryngelsson T, Gustafsson M.

Theor Appl Genet. 1996 Jul;93(1-2):9-14. doi: 10.1007/BF00225720.

PMID:
24162192

Supplemental Content

Loading ...
Support Center